藥明康德(02359.HK)藥明生物(02269.HK)漲5%及8.5%齊創紀錄高
藥明生物(02269.HK)連升第五天,今天股價再突破6月29日盤中所創紀錄高位150.8元,最高見158.9元,現造157.8元,續升8.5%,成交增至747萬股,涉資11.53億元。其母企藥明康德(02359.HK)繼上周五稍作整固後,今天股價也再創上市新高,最高見113.4元,現造113.2元,回升5%。
藥明生物6月30日公布,與配售代理訂立以每股137元(較前個交易日折讓7.9%)配售4,500萬股協議,所得款項擬用於持續全球擴張,包括為治療新冠肺炎及其他相關CDMO項目而於美國興建商業生產設施、於中國境外收購生產設施及於中國興建微生物產品設施等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.